Postdoctoral Students and Visiting Scholars
- Suresh Narayansamy (Current position: Research associate – Ohio State University)
- Nivedita Jena (Current position: Chief Scientific Officer – KIIT Technology Business Incubator)
- Graziella Tocco (Fulbright Scholar; Current position: Assistant Professor – University of Cagliari)
Graduate Students (with PhD Dissertations)
- Dalia Abdelhamid (PhD 2011) Natural products as lead compounds for drug development. I: Synthesis and biological activity of a structurally diverse library of curcumin analogues. II: Synthesis of novel sterol natural products and related analogues as antileishmanial agents. Current position: Assistant Professor, Minia University.
- Pratiq Patel (PhD 2013) Functionalization of nitrogen-containing heterocycles in the synthesis of biologically active molecules. Current position: Research Scientist, Merck.
- Jon Etter (PhD 2013) Development of inhibitors in the IL-6/GP130/JAK/STAT pathway as therapeutic agents. Current position: Medical Resident, University of Michigan.
- John Woodard (PhD 2015) Synthesis and structural optimization of the natural products silvestrol and phyllanthusmin C. Current position: Process Chemist, GlaxoSmithKline.
- Eric Schwartz (PhD 2015) The synthesis and optimization of bioactive natural products as anticancer and antileishmanial agents. Current position: Associate Scientific Liaison, US Pharmacopeia.
- Janet Antwi (PhD 2017) The design, synthesis and optimization of allosteric HIV-1 integrase inhibitors. First position: Assistant Professor, Ohio Dominican University; Current position: Senior Lecturer, Ohio State University College of Pharmacy.
- Yara Mansour (PhD 2017, Helwan University, Egypt) Synthesis and optimization of leads identified as allosteric inhibitors of HIV-1 integrase. Current position: Helwan University
- Chido Hambira (PhD 2018) Post-synthetic functionalization of bioactive compounds for rapid anticancer library expansion and antimicrobial mechanistic probe development. Current position: Postdoctoral researcher, University of British Columbia (Perrin Lab)
- Andrew Huntsman (PhD 2019) Development of phyllanthusmin derivatives as anticancer agents: Pharmacological optimization and mechanistic insight. First position: Medicinal Chemist, Vibliome Therapeutics; Current position: Senior Scientist, Zoetis Inc.
- Tyler Wilson (PhD 2019) Design and synthesis of novel bioactive compounds for the development of HIV-1 allosteric integrase inhibitors, 20S proteasome inhibitors, and anticancer natural product derivatives. Current position: Medicinal Chemist, OSU CCC Med. Chem. Shared Resource.
- Nick Cockroft (PhD 2019) Applications of cheminformatics for the analysis of proteolysis targeting chimeras and the development of natural product computational target fishing models. First position: Data Scientist, Chemical Abstracts Service; Current position: Research Investigator, Arvinas.
- Bo Tokarski (PhD 2020) The 20S proteasome as a target for novel cancer therapeutics: Development of proteasome inhibitors and Proteolysis-Targeting Chimeras (PROTACs). First position: Research Scientist, Charles River Laboratories; Current position: Manager of the Analytical Chemistry Department, Charles River Laboratories, Ashland Ohio.
- Brittney Mize (PhD 2023) Medicinal Chemistry Drug Discovery Efforts Towards Anticancer Leads: The Development of CDK9-Targeting PROTAC and PHY-34 Analogues. Current position: Otterbein University.
- Tosin Ayinde (PhD 2023) Drug Development Efforts Towards Discovery, Characterization and Development of Efficacious Anti-Virulence Agents Against Bacteria and Protein Degraders for Acute Myeloid Leukemia. Current position: Postdoctoral Researcher, National Institutes of Health.
Undergraduate Students
- Aleisha Smith – Kentucky State University
- Mike Corcoran – OSU Biochemistry
- Segun Isaac – Benedict College
- Daniel Akwaboah – OSU Pharmaceutical Sciences (PhD with Craig Forsyth at Ohio State Univ. – Chemistry)
- Caitlin Coffin – OSU Pharmaceutical Sciences
- Samantha Varso – OSU Pharmaceutical Sciences
- Natalie Arkfeld – OSU Pharmaceutical Sciences (PharmD at Ohio State Univ.)
- Kim-My Li – OSU Pharmaceutical Sciences (MD at University of Cincinnati)
- Malcolm Cole – OSU Chemistry/Pharmaceutical Sciences (PhD with Courtney Aldrich at Univ. Minn. – Medicinal Chemistry)
- Rob Demoret – OSU Biochemistry (PhD with Ryan Shenvi at Scripps Research Institute – Chemistry)
- Erica Ham – OSU Pharmaceutical Sciences
- Bernadette Latimer – OSU Chemistry (REVOLUTION Medicines)
- Aimee Ho – OSU Pharmaceutical Sciences/English (PharmD at Univ. of North Carolina)
- Adam Ard – OSU Chemistry (PhD studies with Martin Clasby at Univ. of Michigan – Medicinal Chemistry)
- Jason West – OSU Pharmaceutical Sciences (PhD studies with Mark Mitton-Fry at Ohio State Univ. – Medicinal Chemistry)
- Galina Rozenberg – OSU Pharmaceutical Sciences (PhD studies with Klaus Kaestner at Univ. of Pennsylvania – Pharmacology)
- Kiro Mikhaeel – Kenyon College (PhD studies with David Nagib at Ohio State Univ. – Chemistry)
- Rudra Kamat – OSU Pharmaceutical Sciences
- Carson Takaoka – OSU Chemistry (Vertex Pharmaceuticals)
- Mike Scott – OSU Neuroscience
- Matt Brauser – OSU Pharmaceutical Sciences (PhD studies at Indiana Univ. – Chemistry)